» Articles » PMID: 35877096

Preventive Medication for COVID-19 Infection

Overview
Journal JAMA
Specialty General Medicine
Date 2022 Jul 25
PMID 35877096
Authors
Affiliations
Soon will be listed here.
Citing Articles

Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-CoV-2 in End-Stage Renal Disease Patients on Chronic Hemodialysis: A Single-Center Study.

Nassar M, Sabry A, Elgamal M, Zeid Z, Abdellateif Abdelghany D, Tharwat S Medicina (Kaunas). 2023; 59(12).

PMID: 38138212 PMC: 10744812. DOI: 10.3390/medicina59122109.


SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care.

Wang L, Wang W, Xu R, Berger N Best Pract Res Clin Haematol. 2022; 35(3):101384.

PMID: 36494154 PMC: 9526006. DOI: 10.1016/j.beha.2022.101384.